Autopsy report · NCT00885547

Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis

“low-rate of enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 2 years 2 months before it stopped.
• 90 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Nanjing University School of Medicine

Sponsor type

University, hospital or other

Conditions

IgA Nephropathy

Interventions

tripterygium wilfordii (TW)

Participants

90

Trials that died the same way

• Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
  “Low enrollment rate” (95% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (91% match in meaning)
• Prophylactic Phenobarbital After Neonatal Seizures
  “Inadequate rate of enrollment” (89% match in meaning)
• Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma
  “Low enrollment” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.